Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 11835 | 10.31 |
09:34 ET | 1989 | 10.21 |
09:36 ET | 5934 | 10.23 |
09:38 ET | 1896 | 10.26 |
09:39 ET | 2300 | 10.3212 |
09:41 ET | 2428 | 10.36 |
09:43 ET | 3855 | 10.4 |
09:45 ET | 6952 | 10.29 |
09:48 ET | 11099 | 10.19 |
09:50 ET | 807 | 10.245 |
09:52 ET | 1700 | 10.28 |
09:54 ET | 1377 | 10.22 |
09:56 ET | 1396 | 10.25 |
09:57 ET | 910 | 10.26 |
09:59 ET | 2984 | 10.248 |
10:01 ET | 32134 | 10.16 |
10:03 ET | 6767 | 10.19 |
10:06 ET | 1125 | 10.2 |
10:08 ET | 900 | 10.18 |
10:10 ET | 1448 | 10.205 |
10:12 ET | 4214 | 10.23 |
10:14 ET | 1234 | 10.19 |
10:15 ET | 689 | 10.2 |
10:17 ET | 1200 | 10.2 |
10:19 ET | 2572 | 10.21 |
10:21 ET | 656 | 10.2 |
10:24 ET | 1268 | 10.205 |
10:26 ET | 1129 | 10.19 |
10:28 ET | 3753 | 10.17 |
10:30 ET | 1176 | 10.2 |
10:32 ET | 1744 | 10.18 |
10:33 ET | 3142 | 10.17 |
10:35 ET | 1083 | 10.16 |
10:37 ET | 765 | 10.17 |
10:39 ET | 2383 | 10.19 |
10:42 ET | 4389 | 10.17 |
10:44 ET | 21304 | 10.15 |
10:46 ET | 6918 | 10.24 |
10:48 ET | 2933 | 10.25 |
10:50 ET | 3824 | 10.27 |
10:51 ET | 200 | 10.255 |
10:53 ET | 1524 | 10.2401 |
10:55 ET | 1455 | 10.2344 |
10:57 ET | 1050 | 10.24 |
11:00 ET | 1000 | 10.24 |
11:02 ET | 1713 | 10.255 |
11:04 ET | 900 | 10.23 |
11:06 ET | 902 | 10.2 |
11:08 ET | 1248 | 10.19 |
11:09 ET | 1578 | 10.23 |
11:11 ET | 1404 | 10.2 |
11:13 ET | 400 | 10.16 |
11:15 ET | 1807 | 10.17 |
11:18 ET | 409 | 10.19 |
11:20 ET | 200 | 10.18 |
11:22 ET | 150 | 10.17 |
11:24 ET | 1686 | 10.175 |
11:26 ET | 800 | 10.2 |
11:27 ET | 1596 | 10.19 |
11:29 ET | 2041 | 10.19 |
11:31 ET | 678 | 10.19 |
11:33 ET | 200 | 10.195 |
11:36 ET | 700 | 10.19 |
11:38 ET | 1185 | 10.17 |
11:40 ET | 3014 | 10.15 |
11:42 ET | 2590 | 10.1624 |
11:44 ET | 300 | 10.155 |
11:45 ET | 100 | 10.17 |
11:47 ET | 2838 | 10.18 |
11:49 ET | 1494 | 10.17 |
11:51 ET | 907 | 10.15 |
11:54 ET | 450 | 10.1829 |
11:58 ET | 100 | 10.16 |
12:00 ET | 200 | 10.1634 |
12:02 ET | 1900 | 10.13 |
12:03 ET | 100 | 10.145 |
12:07 ET | 4152 | 10.13 |
12:09 ET | 2053 | 10.14 |
12:12 ET | 700 | 10.12 |
12:14 ET | 3655 | 10.13 |
12:16 ET | 2400 | 10.12 |
12:18 ET | 3174 | 10.1 |
12:20 ET | 1776 | 10.08 |
12:21 ET | 1913 | 10.1 |
12:23 ET | 1110 | 10.09 |
12:25 ET | 100 | 10.09 |
12:27 ET | 1245 | 10.1 |
12:30 ET | 1850 | 10.105 |
12:32 ET | 952 | 10.1 |
12:34 ET | 750 | 10.1 |
12:36 ET | 510 | 10.1 |
12:38 ET | 2250 | 10.1 |
12:39 ET | 3189 | 10.09 |
12:41 ET | 1926 | 10.0984 |
12:43 ET | 5893 | 10.115 |
12:45 ET | 1748 | 10.105 |
12:48 ET | 500 | 10.105 |
12:50 ET | 1900 | 10.11 |
12:52 ET | 978 | 10.19 |
12:54 ET | 100 | 10.2 |
12:56 ET | 3113 | 10.175 |
12:57 ET | 400 | 10.18 |
12:59 ET | 654 | 10.15 |
01:03 ET | 777 | 10.17 |
01:06 ET | 2243 | 10.22 |
01:08 ET | 210 | 10.24 |
01:10 ET | 1502 | 10.21 |
01:12 ET | 1977 | 10.1966 |
01:14 ET | 400 | 10.2085 |
01:15 ET | 1050 | 10.19 |
01:17 ET | 385 | 10.21 |
01:19 ET | 500 | 10.1809 |
01:21 ET | 1200 | 10.21 |
01:24 ET | 700 | 10.215 |
01:26 ET | 2102 | 10.23 |
01:28 ET | 901 | 10.22 |
01:30 ET | 100 | 10.22 |
01:32 ET | 312 | 10.2264 |
01:33 ET | 355 | 10.22 |
01:35 ET | 1300 | 10.21 |
01:37 ET | 1185 | 10.23 |
01:39 ET | 200 | 10.24 |
01:42 ET | 1087 | 10.25 |
01:48 ET | 200 | 10.27 |
01:50 ET | 1548 | 10.29 |
01:51 ET | 100 | 10.29 |
01:53 ET | 287 | 10.3 |
01:55 ET | 200 | 10.33 |
01:57 ET | 200 | 10.33 |
02:00 ET | 200 | 10.33 |
02:06 ET | 2800 | 10.27 |
02:08 ET | 710 | 10.29 |
02:09 ET | 400 | 10.28 |
02:13 ET | 209 | 10.2853 |
02:15 ET | 556 | 10.3 |
02:18 ET | 100 | 10.285 |
02:20 ET | 600 | 10.275 |
02:22 ET | 311 | 10.29 |
02:24 ET | 213 | 10.3 |
02:27 ET | 200 | 10.28 |
02:29 ET | 2117 | 10.335 |
02:31 ET | 1254 | 10.31 |
02:33 ET | 633 | 10.33 |
02:36 ET | 2767 | 10.305 |
02:38 ET | 8140 | 10.2 |
02:40 ET | 5927 | 10.22 |
02:42 ET | 1950 | 10.195 |
02:44 ET | 6361 | 10.19 |
02:45 ET | 1635 | 10.18 |
02:47 ET | 2396 | 10.165 |
02:49 ET | 9291 | 10.15 |
02:51 ET | 6520 | 10.135 |
02:54 ET | 128822 | 10.17 |
02:56 ET | 400 | 10.185 |
02:58 ET | 700 | 10.2 |
03:00 ET | 1026 | 10.24 |
03:02 ET | 648 | 10.24 |
03:03 ET | 750 | 10.26 |
03:05 ET | 438 | 10.28 |
03:07 ET | 656 | 10.33 |
03:09 ET | 620 | 10.31 |
03:12 ET | 305 | 10.31 |
03:14 ET | 300 | 10.32 |
03:16 ET | 751 | 10.31 |
03:18 ET | 1165 | 10.32 |
03:20 ET | 300 | 10.33 |
03:21 ET | 650 | 10.32 |
03:23 ET | 500 | 10.33 |
03:25 ET | 1484 | 10.35 |
03:27 ET | 1300 | 10.34 |
03:30 ET | 1234 | 10.34 |
03:32 ET | 2653 | 10.3 |
03:34 ET | 286 | 10.29 |
03:36 ET | 3244 | 10.3 |
03:38 ET | 4402 | 10.3 |
03:39 ET | 560 | 10.315 |
03:41 ET | 2935 | 10.29 |
03:43 ET | 1553 | 10.31 |
03:45 ET | 1789 | 10.34 |
03:48 ET | 4410 | 10.35 |
03:50 ET | 3118 | 10.34 |
03:52 ET | 4796 | 10.36 |
03:54 ET | 4584 | 10.355 |
03:56 ET | 16354 | 10.38 |
03:57 ET | 23936 | 10.39 |
03:59 ET | 26227 | 10.36 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.4B | -2.6x | --- |
Immatics NV | 1.4B | -12.3x | --- |
Arcus Biosciences Inc | 1.4B | -5.5x | --- |
Prothena Corporation PLC | 1.2B | -6.6x | --- |
Ardelyx Inc | 1.6B | -22.5x | --- |
Arvinas Inc | 1.8B | -4.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 17.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.